Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team at Nuffield Department of Orthopaedic Rheumatology and Musculoskeletal Sciences (NDORMS) has developed a new approach to significantly improve the accuracy of Ribonucleic acid (RNA) sequencing. They pinpoint the primary source of inaccurate quantification in both short and long-read RNA sequencing, and have introduced the concept of “majority vote” error correction leading to a substantial improvement in RNA molecular counting.

Gene sequencing

Accurate sequencing of genetic material is crucial in modern biology, particularly for comprehending and addressing diseases linked to genetic anomalies. However, current methodologies encounter substantial constraints. In a landmark study, an international consortium of researchers, led by Adam Cribbs, Associate Prof in Computational Biology, and Jianfeng Sun, Postdoctoral Research Associate at the Botnar Institute for Musculoskeletal Sciences (NDORMS), have developed an innovative method to correct errors in PCR amplification – a widely used technique used in high-throughput sequencing. By pinpointing PCR artefacts as the primary source of inaccurate quantification, the research, published in Nature Methods, addresses a long-standing challenge in generating accurate absolute counts of RNA molecules, which is crucial for various applications in genomics research.

The researchers focused on Unique Molecular Identifiers (UMIs), which are random oligonucleotide sequences used to remove biases introduced during PCR amplification. While UMIs have been widely adopted in sequencing methods, the study reveals that PCR errors can undermine the accuracy of molecular quantification, particularly across different sequencing platforms.

Jianfeng explained: 'PCR amplification, essential for most RNA sequencing techniques, can introduce errors, compromising data integrity. We tackled this by synthesising UMI barcodes using homotrimer nucleotide blocks, enhancing error correction and enabling near-absolute RNA molecule quantification, markedly improving molecular counting accuracy.'

Read the full story on the Nuffield Department of Orthopaedic Rheumatology  and Musculoskeletal Sciences.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience